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Germline Melanocortin-1-Receptor Genotype Is
Associated with Severity of Cutaneous Phenotype
in Congenital Melanocytic Nevi: A Role for MC1R
in Human Fetal Development
Veronica A. Kinsler1,2, Sayeda Abu-Amero2, Peter Budd3, Ian J. Jackson3, Susan M. Ring4, Kate Northstone4,
David J. Atherton1, Neil W. Bulstrode5, Philip Stanier6, Raoul C. Hennekam7, Neil J. Sebire8,
Gudrun E. Moore2,10 and Eugene Healy9,10
Congenital melanocytic nevi (CMN) are pigmented birthmarks that affect up to 80% of the skin surface area. The
increased frequency of CMN in families of severely affected individuals is suggestive of a predisposing germline
genotype. We noted a high prevalence of red hair in affected families, and considered a role for MC1R in this
condition. A cohort of 166 CMN subjects underwent pigmentary phenotyping, with MC1R genotyping in 113.
Results were compared with a local control group of 60 unrelated children and with 300 UK children without
CMN. CMN subjects had higher prevalences of red hair and a red-haired parent than local controls and had a
higher rate of compound heterozygosity and homozygosity for MC1R variants. The presence of a V92M or R
allele (D84E, R151C, R160W, D294H) was associated with increasing size of the CMN, implying a growth-
promoting effect of these alleles. Unexpectedly, the V92M and R151C alleles were also strongly associated with
birth weight in the CMN cohort, a finding confirmed in the control group. The effect of germline MC1R
genotype on development and severity of CMN led us to investigate potential broader effects on growth,
revealing a role for MC1R in normal fetal development.
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INTRODUCTION
Congenital melanocytic nevi (CMN) are congenital moles
that cover up to 80% of the body surface area and can
number hundreds in a single individual. They are permanent
and grow in proportion to the child, although they often
lighten in color (Strauss and Newton Bishop, 2008; Kinsler
and Bulstrode, 2009; Kinsler et al., 2009b). They are currently
categorized by projected adult size (PAS) of the largest nevus
and by total number of nevi (Ruiz-Maldonado, 2004).
Neurological abnormalities such as neuromelanosis, con-
genital malformations, hydrocephalus, and benign tumors are
the commonest complication of CMN, with the prevalence
increasing with the severity of cutaneous lesions (Kadonaga
and Frieden, 1991; DeDavid et al., 1996; Kinsler et al.,
2008). Primary malignant melanoma of the skin or the CNS is
a much rarer complication in childhood (Hale et al., 2005;
Krengel et al., 2006; Kinsler et al., 2009a), although
almost universally fatal, and prophylactic removal of skin
lesions has not been shown to decrease the risk of
malignancy (Kinsler and Bulstrode, 2009). The recent finding
of characteristic facies in children with CMN has broadened
the description of this condition, and the term CMN
syndrome has been proposed with preliminary diagnostic
criteria (Kinsler et al., Am J Med Genet, 2012 (in press)). The
genetic cause of these syndromic features is likely to be a
somatic change affecting the ectoderm or neural crest, but is
still to be elucidated.
There is, however, evidence of a germline predisposition
for the development of CMN syndrome; this includes a higher
prevalence of smaller CMN in family members of affected
individuals (Kinsler et al., 2009a), together with a handful
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of reports of large CMN in first-degree family members
(Danarti et al., 2003; de Wijn et al., 2010). We hypothesized
that the melanocortin-1-receptor (MC1R) gene might have
a role in this predisposition, on the basis of a clinical
observation of a high prevalence of red hair in families of
children with CMN (for examples see Figure 1). The red
hair/fair skin/freckling phenotype is strongly associated
with variants of MC1R on chromosome 16q24.3 (Valverde
et al., 1995; Box et al., 1997; Schioth et al., 1999;
Healy et al., 2000; Bastiaens et al., 2001). MC1R is a
G-protein-coupled receptor expressed on melanocytes,
melanoma cells, and CMN cells (Ghanem et al., 1988;
Donatien et al., 1992; Mountjoy et al., 1992; Loir et al.,
1999). The gene is highly polymorphic, with over 100
variants reported to date. Variants with a stronger associa-
tion with the red-hair phenotype in humans have been
designated R alleles (D84E, R151C, R160W, and D294H),
whereas those with a weaker association are designated
r alleles (Sturm et al., 2003). This study was undertaken to
examine whether the MC1R genotype influenced the
development of CMN.
RESULTS
A total of 166 children with CMN were included in the study.
The cutaneous phenotype was classified as in Table 1.
Pigmentary phenotype data
Comparisons between affected and unaffected subjects were
restricted to Caucasian subjects of Northern European
ancestry (i.e., white-skinned individuals with four Northern
European grandparents) who constituted the majority of the
study group. Two control groups were ascertained; these
were designated as control groups A (60 unrelated children
from the same school, street, or locality as the affected
individuals) and B (300 UK children without CMN from the
Avon Longitudinal Study of Parents and Children (ALSPAC))
(Jones et al., 2000; Golding et al., 2001). Comparison of the
pigmentary phenotype of the Northern European white
children showed no statistical differences in phenotype
between control groups A and B, although as the numbers
in group A are relatively small we cannot exclude the
possibility that these groups were different in some respect,
and as a result we have used control group B for genotype
ai aii aiii aiv
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Figure 1. Clinical images of children with congenital melanocytic nevi (CMN). Examples of (ai–v) red-haired children with CMN, and (b) different cutaneous
phenotypes of CMN. (i) Projected adult size (PAS) 10–20 cm, (ii) PAS 460 cm with several other nevi also visible. Written, informed consent was obtained for
publication in all cases.
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data. There were significantly fewer blonde/light brown–-
haired individuals in the CMN cohort than in control group A
and separately in control group B (P¼0.0215 and P¼0.0275
respectively; Table 2). In addition, fewer dark brown/black-
haired individuals were present in the CMN cohort than in
control group A (P¼0.0293), whereas this was similar in the
CMN cohort and control group B. Conversely, CMN children
were more likely to have red hair than the larger control
group B (P¼0.0085), whereas this was not significantly
different from the number of red-haired children in control
group A. However, CMN children were more likely to have at
least one red-haired parent (32 of 107 (30%)) than control
group A (1 of 47 (2%)), respectively (Po0.0001), evenly
divided between mothers and fathers. Parental pigmentary
phenotype was not available for control group B. The
pigmentary phenotype of the Northern European white
children is shown in Table 2.
MC1R variants, particularly the R alleles, are known to be
causally associated with red hair (Valverde et al., 1995; Box
et al., 1997; Smith et al., 1998; Sulem et al., 2007), and
there is some evidence that the MC1R genotype may be
associated with blonde/light brown hair (Box et al., 1997;
Smith et al., 1998). On the basis of these phenotypic
observations between affected and unaffected groups, we
hypothesized that the MC1R genotype may influence the
development of CMN.
MC1R genotype data
According to the phenotyping described above, comparison
of the MC1R gene between cohorts was restricted to white-
skinned children of Northern European ancestry. To ensure
sufficient numbers for statistical analysis of prevalence of
MC1R polymorphisms, members of the affected group and
control group B were sequenced for MC1R. Individuals with
CMN were more likely to have twoMC1R variant alleles than
controls (P¼ 0.0052, Table 3). More detailed analysis
indicated that this was not due to a difference in the
frequency of a particular MC1R variant between these two
groups (see Supplementary table S1 online). The MC1R
genotype in three pairs of affected and unaffected skin
samples was identical with the germline genotypes, suggest-
ing that somatic MC1R mosaicism was not the causative
feature of affected versus unaffected skin.
In addition to coding region variants, a known SNP in the
30 UTR (rs3212369) was found at a high frequency in both
populations, and found to cosegregate strongly but not
exclusively with the V92M and T314T alleles (Po0.001 for
Pearson’s correlation coefficients on all combinations of
two variables). However, as an extension to previous reports
(Harding et al., 2000), the pattern of segregation suggested
that this SNP arose independently of the T314T variant. This
implies that either the V92M variant arose twice indepen-
dently, on the 30 UTR (rs3212369) and T314T alleles, or that
there was intragenic recombination within MC1R.
Association between the MC1R genotype and CMN phenotype
In the CMN cohort, the presence of a V92M or an R allele
(D84E, R151C, R160W, D294H) was found to be signifi-
cantly associated with increasing projected adult size (PAS) of
the largest CMN (P¼ 0.01) (Figure 2). We examined this
Table 1. Cutaneous phenotype of the CMN cohort
Projected adult size of
largest CMN (cm) N (%) Site of largest CMN N (%)
o10 35 (21) Face 10 (6)
10–20 28 (17) Scalp 19 (12)
20–40 27 (16) Neck 85 (51)
40–60 24 (15) Trunk 25 (15)
460 48 (29) Scalp/neck/trunk 9 (6)
No single larger lesion 4 (2) Face/scalp 14 (8)
Missing data 0 No single larger lesion 4 (2)
Missing data
Total 166 (100) Total 166 (100)
Total number of other nevi
at birth
N (%) Total number of other
nevi at enrollment
N (%)
0 28 (17) 0 28 (17)
1–10 37 (22) 1–10 25 (15)
11–20 25 (15) 11–20 20 (12)
21–50 26 (16) 21–50 19 (11)
51–100 17 (10) 51–100 22 (13)
101–200 8 (5) 101–200 28 (17)
4200 3 (2) 4200 18 (11)
Missing data 22 (13) Missing data 6 (4)
Total 166 (100) Total 166 (100)
Abbreviation: CMN, congenital melanocytic nevi.
Table 2. Pigmentary phenotype of the CMN cohort
and control groups
CMN cohort
(N=129)
Control group A
(N=55)
Control group B
(N=287)
Predominant
hair color
Blonde/light
brown
83/119 (69.7) 46/53 (86.8) 230/287 (80.1)
Dark brown/
black
25/119 (21.0) 4/53 (7.5) 49/287 (17.1)
Red 11/119 (9.3) 3/53 (5.7) 8/287 (2.8)
Peripheral predominant iris color
Blue/gray 69/107 (64.5) 34/54 (63.0) 164/287 (57.2)
Green/hazel 12/107 (11.2) 10/54 (18.5) 69/287 (24.0)
Dark brown 26/107 (24.3) 10/54 (18.5) 54/287 (18.8)
Freckles 24/110 (21.8) 19/54 (35.2) 77/287 (26.8)
Abbreviation: CMN, congenital melanocytic nevi.
Numbers shown are absolute values with percentages in brackets.
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effect in more detail using 460 cm PAS as a cutoff, as this
has previously been noted to be a significant predictor for
increased incidence of malignant melanoma (Demenais
et al., 2010). The odds ratio for having a CMN of PAS
460 cm compared with those ofo60 cm if carrying V92M or
an R allele was 2.867 (95% CI 1.1257–6.537, P¼0.012).
Association between the MC1R genotype and family history of
CMN
Thirty-four percent of the children with CMN had a first- or
second-degree family history of CMN. If the MC1R genotype
were one of the predisposing factors for development of
CMN, a difference in MC1R genotype between those with
and without a positive family history of CMN would be
expected. This was indeed the case, with a significantly
higher prevalence of at least one MC1R variant in those with
a family history of CMN versus those in whom no first- or
second-degree relative had a CMN (91 vs. 59% respectively,
P¼0.0062). When confined to the V92M and/or R alleles, a
similar preponderance of variants was noted in CMN
children with a family history versus those without a family
history of CMN (65 vs. 30%, P¼0.018).
Association of the MC1R genotype and birth weight
The above results, in which MC1R variants were associated
with larger CMN and more nevi, indicate that the MC1R
genotype influences the development of CMN. However, an
additional possibility is the existence of a broader role for
MC1R genotype in fetal growth and development, especially
thatMC1R variants function in promoting growth of the fetus.
Therefore, we examined for associations between V92M and
R alleles and birth weight in the CMN cohort and control
group B. The presence of a V92M or R151C was significantly
associated with increased birth weight in the CMN cohort
(unstandardized coefficient þ697 g, SE 216 g, P¼0.002),
independent of gender and maternal smoking (Figure 3a).
A similar significant effect of the same MC1R alleles was
observed on birth weight (þ187 g, SE 59 g, P¼ 0.002) in the
ALSPAC cohort, control group B (Figure 3b). This effect
was independent of sex, gestation, maternal smoking, maternal
weight pre-pregnancy, and maternal hypertension. Thus, the
magnitude of this genotype effect is comparable to the effect of
gender in this study. There was no significant association
between R alleles as a group and birth weight in either cohort.
No association between postnatal weight at the age of 49
months and MC1R genotype was found in control group B.
DISCUSSION
Previous studies of the effects of MC1R genotype in postnatal
life have documented fewer acquired melanocytic nevi in
red-haired children and adults (Duffy et al., 2004; Dellavalle
et al., 2005), and in individuals homozygous or compound
heterozygous for R alleles at the MC1R locus (Duffy et al.,
2004). In addition, genome-wide association studies have not
found any association betweenMC1R genotype and numbers
of acquired melanocytic nevi (Falchi et al., 2006; Yeh and
Bastian, 2009), and no association between MC1R variants
and higher numbers of acquired nevi in families with inheri-
ted melanoma (Demenais et al., 2010). However, in the current
study, we have identified associations between families with
CMN-affected children and the red hair pigmentary phenotype,
and associations between MC1R variants and the presence of
CMN, as well with more extensive CMN. Taken in the context
of the effect on birth weight, this difference between congenital
and acquired nevi may be due to the differential effects of
MC1R during pre- and postnatal life, although other inherent
genetic differences between congenital and acquired nevi
could also be significant factors.
Table 3. Comparison of prevalence of carriage of non-
synonymous MC1R variants found in the white
Northern European Caucasian children of the CMN
cohort and control group B
CMN cohort,
N (%)
Control group
B, N (%)
Fisher’s exact
P-value
Wild type 17/84 (20.2) 82/267 (30.7) 0.0711
Heterozygous 40/84 (47.6) 139/267 (52.1) 0.5320
Compound heterozygous 20/84 (23.8) 39/267 (14.6) 0.0647
Homozygous 7/84 (8.3) 7/267 (2.6) 0.0478*
Compound heterozygous
or homozygous
27/84 (32.1) 46/267 (17.2) 0.0052**
Total 84/84 (100) 267/267 (100)
Abbreviation: CMN, congenital melanocytic nevi.
Significance at 0.05 level* and **0.01 level.
Child R allele
or V92M
< 10 cm < 10–20 cm 20–40 cm
Largest CMN projected adult size
40–60 cm > 60 cm
No
Yes
Figure 2. Association between MC1R genotype and severity of cutaneous
phenotype in congenital melanocytic nevi (CMN). Dot plot of proportions of
V92M- or R allele–positive individuals with increasing projected adult size of
largest CMN.
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Our findings indicate that certain MC1R variants function
to promote the growth of CMN during embryogenesis, and
possibly the growth of the fetus as a whole. The exact
mechanism whereby MC1R variants alter fetal growth and
development are unknown, but might involve direct effects
on the fetus and/or indirect effects through the presence of
MC1R on trophoblast cells of the placenta (Thornwall et al.,
1997). MC1R is expressed on a wide range of adult human
cell types including adipocytes (Hoch et al., 2007; www.
genecards.com; Rebhan et al., 1997), supporting the increas-
ing body of evidence that it has significant non-pigmentary
roles (Robinson and Healy, 2002; Mogil et al., 2005;
Robinson et al., 2010); alpha-MSH is involved in metabolic
pathways, but this is currently understood to be via the other
melanocortin receptors. Melanocortin-1-receptor (MC1R)
genotype is known to interact with pigmentary and non-
pigmentary pathways (Robinson and Healy, 2002; Cooper
et al., 2005; Robinson et al., 2010), for example, altering the
penetrance of other genes in melanoma such as p53 (Patton
et al., 2005; Stefanaki et al., 2007; Nan et al., 2008) and
CDKN2A (Box et al., 2001; Debniak et al., 2006). The latter
effects are dependent not only on particular alleles but also
on the number of variant alleles present (Demenais et al.,
2010). A similar interactive effect may be operating in
individuals with CMN, with MC1R variants exerting a
phenotype-exacerbating effect on a different somatic, or
possibly germline, genetic alteration that affects CMN
development. The effect of MC1R genotype on birth weight
in our study was a generalized phenomenon that was found
in two separate cohorts (CMN and ALSPAC), and in the
MC1R-pigmentary context the previously reported interactive
effects of MC1R genotype on oculocutaneous albinism (King
et al., 2003) was a generalized, rather than localized, effect
on pigmentation. The fact that in the ALSPAC cohort of
healthy children the larger birth weight in subjects with
MC1R variants was not associated with any other dysmorphic
features suggests that in the normal situation MC1R genotype
may influence fetal development to affect body size in a
proportionate manner. Interactive effects of MC1R with other
genes affecting birth weight have not yet been investigated,
and further work on this topic will be required in the future.
MC1R variants are a risk factor for melanoma development
in the general population and are associated with increased
risk of melanoma in CDKN2A mutation carriers (Box et al.,
2001; Demenais et al., 2010). One important clinical
consideration in our patient cohort is whether the pattern of
germline MC1R genotype is responsible for the excess risk of
malignant melanoma in individuals with CMN. The lifetime
risk for melanoma is around 1–2% when all CMN are
considered together as a group (Krengel et al., 2006; Kinsler
et al., 2009a), which is similar in magnitude to the excess risk
associated with MC1R variants in the normal population. The
numbers of melanomas in our CMN cohort are too few to
allow detailed investigations on the risk of melanoma
attributable toMC1R variants, but it is likely that this genotype
is at least contributing to melanoma risk. In a recent family-
based melanoma study, the odds ratio for melanoma in
CDKN2A mutation carriers was 5.67 (95% CI 2.1–15.29) for
subjects with MC1R variants (Demenais et al., 2010); thus, it
is possible that theMC1R genotype may similarly alter the risk
of melanoma in people with larger CMNs.
In conclusion, we have identified associations between
CMN and red-hair/MC1R variants. Furthermore, the presence
of a V92M or R allele was associated with larger CMN size
and with larger birth weight in the CMN, and separately in
the ALSPAC, groups consistent with a growth-promoting
effect of these alleles during embryogenesis.
MATERIALS AND METHODS
This study was approved by the research ethics committee of Great
Ormond Street Hospital for Children/Institute of Child Health,
London. All aspects of this study comply with the Declaration of
Helsinki Principles. Written, informed consent was given by parents
in all cases, and by subjects, where appropriate.
CMN cohort
In all, 166 families with children with CMN were recruited for
pigmentary phenotyping during clinical consultations, and offered
MC1R genotyping. CMN phenotype was classified as previously
published (Ruiz-Maldonado, 2004; Kinsler et al., 2008, 2009a, 2009b)
(Table 1; for examples see Figure 1). The total number of nevi at birth
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Figure 3. Association between MC1R genotype and birth weight. Effect of
the presence of V92M or R151C alleles on birth-weight standard deviation
score (SDS) in (a) the congenital melanocytic nevi (CMN) cohort, and
(b) control group B. SDS includes the effects of gestation and sex, and a score
of þ1 is equivalent to an increase in one SD from the mean of the population.
Error bars are 95% confidence intervals.
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was ascertained by history, direct examination, or photographs. Mean
and median ages at enrollment to the study were 5.02 years (SEM
0.53) and 2.54 years (range 0.03–43.12), respectively. Follow-up during
the study period was for a mean of 3.09 years and median of
3.12 years. Pigmentary phenotyping was performed by a single
observer (VK) and was assessed after 1 year of age because of
the changes frequently seen in hair and eye color in the first year.
Hair color was classified using a chart of 12 colors; eye color was
grouped into six standard colors, with peri-pupillary and predo-
minant background iris color considered separately; freckling was
recorded by grouped number and distribution; and skin type was
assessed using the Fitzpatrick score. Pigmentary phenotype was
obtained for 148 children, 143 mothers, and 130 fathers. Ancestry,
up to the four grandparents, was also recorded; patients were classified
as white Northern European Caucasians if their skin color was white
and if all four of their grandparents were born in Northern Europe.
Consent was obtained for MC1R genotyping in 113 families. Adequate
blood samples for DNA extraction were obtained from 104 children,
78 mothers, and 58 fathers. With further written consent, three children
had skin biopsies taken from affected and unaffected skin, whereas
they were undergoing general anesthesia for other procedures.
Control group A
With the assistance of the CMN families, we recruited a geographi-
cally matched and sex-matched control population of individuals
without CMN. Sixty families completed the same pigmentary
phenotyping questionnaires as the CMN group, with telephone
guidance from the same researcher. Fifty-five were white Northern
European Caucasians, i.e., four grandparents born in Northern
Europe; the mean and median age of these 55 children was 7.2 years
(SEM 1.1) and 5.6 years (range 0.7–37.6), respectively. To check
whether self-reported phenotypes were accurate, 25 CMN families
(66 individuals) completed the pigmentary phenotype questionnaire
before undergoing face-to-face phenotyping. Pearson’s correlations
for hair color and eye color were 0.509 and 0.855, respectively,
significant at o0.05 level, supporting the use of self-reported
questionnaires in this context.
Control group B
Ethical approval for this part of the study was obtained from the
ALSPAC Law and Ethics Committee and the Local Research Ethics
Committees. The children in this group born in 1992 had face-to-
face pigmentary phenotyping by trained observers at the age of 49
months, and the presence of CMN was noted. The 300 samples were
chosen randomly from those without CMN. Pigmentary phenotyping
in the ALSPAC study was performed by trained research nurses as
follows: hair color was compared with 11 real-hair swatches of mea-
sured luminosities, eye color was compared with six standard iris
photographs, and skin reflectance was measured by spectrophot-
ometer. MC1R genotyping was performed for all 300 samples, with
270 reliable results for Northern European Caucasian white children.
MC1R genotyping
DNA was extracted directly from all samples using standard
extraction procedures. The 951 coding base pairs of the single exon
of MC1R, as well as a further 416 base pairs of the 30 UTR, were
amplified by PCR as a single product and sequenced using four
overlapping primer sets (50-TCCAGCCAGGGAGAGGGTGTGA-30
and 50-AGCTGCAGGTGATCACGTCAAT-30; 50-CTCACCCATGTAC
TGCTTCA-30 and 50-GAGTGTGAGATGCAGGAAGAAG-30; 50-CTC
ATGGCCGTGCTGTACGT-30 and 50-CTTTGACAAACGGGGACCA
G-30; 50-ACGCTCAAGGAGGTGCTGACAT-30 and 50-CCACCCAG
AGACTTCACAT-30).
Birth-weight analysis
In the CMN cohort, data on birth weight and maternal smoking were
available for 128 children. Pre-term children were excluded on the
basis that there might have been other abnormalities during the
pregnancy that could confound any genotype effect. In control
population B, data were available for birth weight, gestation,
maternal smoking, maternal weight before pregnancy, and maternal
hypertension for all children.
Statistical analysis
Comparisons of prevalence between groups (pigmentary character-
istics and MC1R genotype) were made by Fisher’s exact test.
Analysis of the statistical effect of genotype on CMN phenotype and
on birth weight was by ordinal and linear logistic regression analysis,
respectively. For the MC1R genotype associations, we tested the
following four variables initially against projected adult size of the
main nevus: V92M, V60L, R163Q, and R alleles (grouped together,
as they are known to be a clinically and physiologically cohesive
group, but some are rare alleles); other alleles were excluded from
this analysis as they were found in o5% of our population. To
improve our model fit, we then combined the V92M and R allele
groups to make the variable V92M or R allele. A Bonferroni
correction was applied, reducing the level of significance from 0.05
to less than 0.0102062 (i.e., for a total of five statistical tests). We
then used this combined variable, V92M or R allele, to test against
birth weight in the CMN cohort, with a further refinement made to
the model by using V92M combined with R151C (the commonest of
the R alleles), to make the variable V92M or R151C. Again, with a
Bonferroni correction (for two tests), this reduced the level of
significance (P-value) from 0.05 to 0.0253206. For genotype testing
against birth weight in the control group, we tested the single
variable V92M or R151C.
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